Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas M Smith

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|January 26, 2021
Interaction of Staphylococcus aureus and Acinetobacter baumannii during <i>In Vitro</i> β-Lactam ExposureNicholas M Smith, Alexa Ang, Fanny Tan, et al.
Frontiers in Pharmacology|June 19, 2024
Influence of β-lactam pharmacodynamics on the systems microbiology of gram-positive and gram-negative polymicrobial communitiesNicholas M Smith, Harpreet Kaur, Ravneet Kaur, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|February 17, 2018
Evaluating the Effect of Six Proton Pump Inhibitors on the Antiplatelet Effects of ClopidogrelEugene R Przespolewski, Erica S Westphal, Michelle Rainka, et al.
International Journal of Antimicrobial Agents|December 28, 2020
Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal PrecisionHubert C Chua, Andy Tse, Nicholas M Smith, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2019
Bacterial brothers in arms: cooperation of Staphylococcus aureus and Pseudomonas aeruginosa during antimicrobial exposureJustin R Lenhard, Nicholas M Smith, Christine D Quach, et al.
Advances in Experimental Medicine and Biology|August 1, 2019
Rational Combinations of Polymyxins with Other AntibioticsPhillip J Bergen, Nicholas M Smith, Tyler B Bedard, et al.
Jac-Antimicrobial Resistance|May 5, 2025
Pharmacodynamics of aztreonam/ceftazidime/avibactam and polymyxin B versus New Delhi MBL-producing Acinetobacter baumanniiJacob T Dumbleton, Anant P Shah, Brian M Ho, et al.
Pharmacotherapy|July 15, 2023
Bayesian optimization of tacrolimus exposure in stable kidney transplant patientsThomas D Nguyen, Nicholas M Smith, Kris Attwood, et al.
BMC Complementary and Alternative Medicine|November 5, 2016
In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetesPermal Deo, Erandi Hewawasam, Aris Karakoulakis, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2025
Whole-body distribution of three <i>Pseudomonas</i> phages characterized by a translational physiologically based pharmacokinetic modelArne Echterhof, Tejas Dharmaraj, Patrick Blankenberg, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|January 26, 2021
Interaction of Staphylococcus aureus and Acinetobacter baumannii during <i>In Vitro</i> β-Lactam ExposureNicholas M Smith, Alexa Ang, Fanny Tan, et al.
Frontiers in Pharmacology|June 19, 2024
Influence of β-lactam pharmacodynamics on the systems microbiology of gram-positive and gram-negative polymicrobial communitiesNicholas M Smith, Harpreet Kaur, Ravneet Kaur, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|February 17, 2018
Evaluating the Effect of Six Proton Pump Inhibitors on the Antiplatelet Effects of ClopidogrelEugene R Przespolewski, Erica S Westphal, Michelle Rainka, et al.
International Journal of Antimicrobial Agents|December 28, 2020
Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal PrecisionHubert C Chua, Andy Tse, Nicholas M Smith, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2019
Bacterial brothers in arms: cooperation of Staphylococcus aureus and Pseudomonas aeruginosa during antimicrobial exposureJustin R Lenhard, Nicholas M Smith, Christine D Quach, et al.
Advances in Experimental Medicine and Biology|August 1, 2019
Rational Combinations of Polymyxins with Other AntibioticsPhillip J Bergen, Nicholas M Smith, Tyler B Bedard, et al.
Jac-Antimicrobial Resistance|May 5, 2025
Pharmacodynamics of aztreonam/ceftazidime/avibactam and polymyxin B versus New Delhi MBL-producing Acinetobacter baumanniiJacob T Dumbleton, Anant P Shah, Brian M Ho, et al.
Pharmacotherapy|July 15, 2023
Bayesian optimization of tacrolimus exposure in stable kidney transplant patientsThomas D Nguyen, Nicholas M Smith, Kris Attwood, et al.
BMC Complementary and Alternative Medicine|November 5, 2016
In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetesPermal Deo, Erandi Hewawasam, Aris Karakoulakis, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2025
Whole-body distribution of three <i>Pseudomonas</i> phages characterized by a translational physiologically based pharmacokinetic modelArne Echterhof, Tejas Dharmaraj, Patrick Blankenberg, et al.
Pageof 4